Processa Pharmaceuticals, Inc. (PCSA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.77M |
| Enterprise Value | -1.77M |
| P/E Ratio | -0.03 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.03 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 11.39 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.06 |
| Return On Equity | -4.11 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -13.56M |
| Net Income | -13.56M |
| Diluted EPS | -10.36 |
| Total Cash | 180.21M |
| Total Cash/Share | 60.73 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 97.7 |
| Book Value Per Share | 60.57 |
| 52-Week Change | -77.39 |
| 52-Week High | 8.88 |
| 52-Week Low | 1.04 |
| Moving Average 50 Days | 1.8 |
| Moving Average 200 Days | 2.29 |
| Average Volume | 79,809 |
| Shares Outstanding | 2.8M |
| % Held by Institutions | 4.31 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | December 17, 2025 |